Search results
Panel recommends FDA reject MDMA as treatment for PTSD
Washington Post· 17 hours agoA U.S. Food and Drug Administration advisory committee overwhelmingly voted Tuesday that evidence is...
Psychedelic Drug MDMA Faces FDA Panel in Bid to Become First-Of-A-Kind PTSD Medication
US News & World Report· 19 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest research on the ...
FDA panel to review psychedelic drug MDMA for first time
Reuters· 24 hours agoA panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a...
Supporters think ecstasy has potential to treat PTSD, but FDA panel rejects psychedelic drug
KABC 7 Los Angeles· 5 hours agoFederal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD....
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
San Francisco Chronicle· 9 hours agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 19 hours agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
Panel rejects psychedelic drug MDMA as a PTSD treatment in setback for advocates
Los Angeles Times· 11 hours agoThe panel of advisers to the Food and Drug Administration sided 10-1 against the overall benefits of...
J&J seeks expanded approvals for paediatric HIV-1 therapy
Pharmaceutical Technology via Yahoo Finance· 2 hours agoJohnson & Johnson (J&J) has filed a supplemental new drug application (sNDA) with the US Food and ...
MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
San Jose Mercury News· 17 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
KNOP North Platte· 12 hours agoThe panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of...